Galderma

Galderma is a global dermatology-focused company established in 1981, originally as a joint venture between Nestle and L'Oreal. It became a standalone entity in 2019 and is dedicated to providing innovative medical solutions for various dermatological conditions throughout the lifespan of individuals. With a workforce of approximately 6,600 employees and a presence in 80 countries, Galderma offers a diverse product portfolio that addresses issues such as acne, rosacea, psoriasis, and skin cancer. Key brands include Epiduo, Oracea, Differin, and Restylane, among others. The company emphasizes a science-based approach across multiple dermatology categories, including therapeutic solutions, dermatological skincare, and injectable aesthetics.

Jean Falconnet

Vice President of Corporate Development and M&A and Head of Transactions

3 past transactions

Alastin Skincare

Acquisition in 2021
Alastin Skincare is a California-based company that specializes in developing innovative and clinically-validated skincare products aimed at enhancing and maintaining healthy skin. Founded in 2015 and located in Carlsbad, the company focuses on creating physician-dispensed products that utilize advanced technology and a proprietary blend of peptides to support the skin's natural regeneration processes. Their offerings include solutions for both ablative and non-ablative rejuvenating procedures, ensuring that dermatologists and plastic surgeons can effectively assist their patients in correcting, protecting, and preserving their skin health. Alastin Skincare emphasizes safety and effectiveness through rigorous clinical testing of its products.

Q-Med

Acquisition in 2011
Q-Med is a medical device company that specializes in the development, manufacturing, marketing, and sale of medical implants. The company is known for its patented technology, NASHAâ„¢, which enables the production of stabilized non-animal hyaluronic acid. Q-Med's product portfolio includes implants utilized in various medical fields, such as aesthetics, uro-gynecology, cell therapy, and encapsulation. By focusing on innovative solutions, Q-Med aims to address specific medical needs while enhancing patient outcomes.

CollaGenex Pharmaceuticals

Acquisition in 2008
CollaGenex Pharmaceuticals is a medical company based in Newtown, Pennsylvania, specializing in the development and marketing of innovative proprietary therapies for the dermatology market. The company's focus is on creating advanced medical treatments aimed at addressing various skin conditions, thereby contributing to advancements in dermatological healthcare.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.